This document discusses the role of NF-κB in regulating apoptosis. It describes how NF-κB is a transcription factor that regulates the expression of many anti-apoptotic genes. The regulation of NF-κB involves its interaction with the inhibitory protein IκB and transport between the cytoplasm and nucleus. Phosphorylation of IκB leads to its degradation and the release of NF-κB to enter the nucleus and activate gene transcription. This tight regulation of NF-κB activity and localization determines whether a cell survives or undergoes apoptosis.
In Situ Polymerase Chain Reaction (In situ PCR) is a powerful method that detects minute quantities of rare or single-copy number nucleic acid sequences in frozen or paraffin-embedded cells or tissue sections for the localization of those sequences within the cells. The principle of this method involves tissue fixing (to preserve the cell morphology) and subsequent treatment with proteolytic digestion (to provide access for the PCR reagents to the target DNA). The target sequences are amplified by those reagents and then detected by standard immunocytochemical protocols. In situ PCR combines the sensitivity of PCR or RT-PCR amplification along with the ability to perform morphological analysis on the same sample, and thus it is an attractive tool in diagnostic applications. One of the most prominent applications is the detection of infectious disease agents including HIV-1, HBV, HPV, HHV-6, CMV, and EBV.
In Situ Polymerase Chain Reaction (In situ PCR) is a powerful method that detects minute quantities of rare or single-copy number nucleic acid sequences in frozen or paraffin-embedded cells or tissue sections for the localization of those sequences within the cells. The principle of this method involves tissue fixing (to preserve the cell morphology) and subsequent treatment with proteolytic digestion (to provide access for the PCR reagents to the target DNA). The target sequences are amplified by those reagents and then detected by standard immunocytochemical protocols. In situ PCR combines the sensitivity of PCR or RT-PCR amplification along with the ability to perform morphological analysis on the same sample, and thus it is an attractive tool in diagnostic applications. One of the most prominent applications is the detection of infectious disease agents including HIV-1, HBV, HPV, HHV-6, CMV, and EBV.
Epileptogenesis is the process by which a brain network that was previously normal is functionally altered toward increased seizure susceptibility, thus having an enhanced probability to generate spontaneous recurrent seizures (SRSs). The process of epileptogenesis occurs in 3 phases: the occurrence of a precipitating injury; a 'latent' period of epileptogenesis and chronic, established epilepsy. Structural and molecular changes associated with epileptogenesis include selective neuronal loss,axonal and dendritic reorganisation, neurogenesis, altered expression of neurotransmitters, and changes at glial architecture. Antiepileptogenesis can be complete or partial. Complete prevention aborts the development of epilepsy while partial prevention can delay the development of epilepsy or reduce its severity. Targeting signaling pathways that alter the expression of genes involved in epileptogenesis may provide novel therapeutic approaches for preventing epileptogenesis. The mTOR and REST pathways are exciting new potential targets for intervention in the epileptogenic process.
ANESTHETIC CONSIDERATIONS FOR STEREOTACTIC ELECTROENCEPHALOGRAPHY (SEEG) IMP...Anurag Tewari MD
The refractory seizures have significant impact on the quality of life and increase long term neurologic and non-neurologic complications. Implantation of Stereotactic Electroencephalography (SEEG) leads is one of the newer surgical techniques intended to localize seizure foci with higher accuracy than the conventional methods. Most of the commonly utilized anesthetic agents depress EEG waveforms affecting intra operative monitoring during these surgeries. Hence, the anesthetic goals include a stable induction and maintenance with agents which have minimal effect on EEG. This article discusses the peri-operative considerations of multiple anti-epileptic medications, recent advances in anesthetic management, and important post-operative concerns.
Keywords: Anesthesia, epilepsy surgery, intra-operative EEG, intra operative monitoring, refractory seizures, SEEG, seizure foci, stereotactic electroencephalography
1. INTRODUCTION
2. REACTIVE OXYGEN SPECIES
3. FREE RADICALS
4. ROLE OF R.O.S.
5. EFFECTS OF R.O.S.
6. OXIDATIVE DNA DAMAGE
7. SOURCES OF R.O.S.
8. R.O.S. & BODY'S DEFENSE SYSTEMS
9. MAPK PATHWAYS & DETOXIFICATION OF R.O.S.
10. DEFENSE MECHANISM
11. NRF2 ACTIONS
12. PROTEIN STRUCTURE OF NRF2 & KEAP1
13. ROLE OF NRF2 IN DEFENSE MECHANISMS
The change in one nucleotide in a genome is known as single nucleotide polymorphism. There are assorted types of SNPs. SNPs can be detected by several analytical techniques i.e. DNA sequencing, microchip, HPLC and oligonucleotide ligation reaction.
Introduction to second generation sequencingDenis C. Bauer
An introduction to second generation sequencing will be given with focus on the basic production informatics: The approach of raw data conversion and quality control will be discussed.
KDM5 epigenetic modifiers as a focus for drug discoveryChristopher Wynder
A summary presentation of my scientific work.
My laboratory focused on an enzyme KDM5b (aka PLU-1, JARID1b) that was widely expressed during development and played a key role in progression of breast cancer through HER-2.
My lab focused on understanding the key biochemical activity of the enzyme through dissecting the proteomic and genomic interactors.
Our results were confirmed through the use of ES cells, adult stem cells and mouse models.
Much of this work remains unpublished, please contact me for more information and/or access to any reagents that I still have as part of this work.
crwynder@gmail.com
Epileptogenesis is the process by which a brain network that was previously normal is functionally altered toward increased seizure susceptibility, thus having an enhanced probability to generate spontaneous recurrent seizures (SRSs). The process of epileptogenesis occurs in 3 phases: the occurrence of a precipitating injury; a 'latent' period of epileptogenesis and chronic, established epilepsy. Structural and molecular changes associated with epileptogenesis include selective neuronal loss,axonal and dendritic reorganisation, neurogenesis, altered expression of neurotransmitters, and changes at glial architecture. Antiepileptogenesis can be complete or partial. Complete prevention aborts the development of epilepsy while partial prevention can delay the development of epilepsy or reduce its severity. Targeting signaling pathways that alter the expression of genes involved in epileptogenesis may provide novel therapeutic approaches for preventing epileptogenesis. The mTOR and REST pathways are exciting new potential targets for intervention in the epileptogenic process.
ANESTHETIC CONSIDERATIONS FOR STEREOTACTIC ELECTROENCEPHALOGRAPHY (SEEG) IMP...Anurag Tewari MD
The refractory seizures have significant impact on the quality of life and increase long term neurologic and non-neurologic complications. Implantation of Stereotactic Electroencephalography (SEEG) leads is one of the newer surgical techniques intended to localize seizure foci with higher accuracy than the conventional methods. Most of the commonly utilized anesthetic agents depress EEG waveforms affecting intra operative monitoring during these surgeries. Hence, the anesthetic goals include a stable induction and maintenance with agents which have minimal effect on EEG. This article discusses the peri-operative considerations of multiple anti-epileptic medications, recent advances in anesthetic management, and important post-operative concerns.
Keywords: Anesthesia, epilepsy surgery, intra-operative EEG, intra operative monitoring, refractory seizures, SEEG, seizure foci, stereotactic electroencephalography
1. INTRODUCTION
2. REACTIVE OXYGEN SPECIES
3. FREE RADICALS
4. ROLE OF R.O.S.
5. EFFECTS OF R.O.S.
6. OXIDATIVE DNA DAMAGE
7. SOURCES OF R.O.S.
8. R.O.S. & BODY'S DEFENSE SYSTEMS
9. MAPK PATHWAYS & DETOXIFICATION OF R.O.S.
10. DEFENSE MECHANISM
11. NRF2 ACTIONS
12. PROTEIN STRUCTURE OF NRF2 & KEAP1
13. ROLE OF NRF2 IN DEFENSE MECHANISMS
The change in one nucleotide in a genome is known as single nucleotide polymorphism. There are assorted types of SNPs. SNPs can be detected by several analytical techniques i.e. DNA sequencing, microchip, HPLC and oligonucleotide ligation reaction.
Introduction to second generation sequencingDenis C. Bauer
An introduction to second generation sequencing will be given with focus on the basic production informatics: The approach of raw data conversion and quality control will be discussed.
KDM5 epigenetic modifiers as a focus for drug discoveryChristopher Wynder
A summary presentation of my scientific work.
My laboratory focused on an enzyme KDM5b (aka PLU-1, JARID1b) that was widely expressed during development and played a key role in progression of breast cancer through HER-2.
My lab focused on understanding the key biochemical activity of the enzyme through dissecting the proteomic and genomic interactors.
Our results were confirmed through the use of ES cells, adult stem cells and mouse models.
Much of this work remains unpublished, please contact me for more information and/or access to any reagents that I still have as part of this work.
crwynder@gmail.com
Regulation of KDM5 by multiple cofactors regulates cancer and stem cellsChristopher Wynder
Presentation of data regarding proteins that regulate the activity of KDM5b.
The studies use multiple disciplines including in vitro enzymology, ES cell studies of differentiation, Mass spectrometry to detect protein protein interactions.
These studies resulted in a comprehensive view of KDM5b function. It required development of at least three novel assays that are focused on moving epigenetic research from yeast and HeLa cell types to primary, clinically relevant cell types.
The techniques have been successfully used in Embryonic stem cells (human and mouse), Neural stem cells (mouse and patient derived as well as iPSCs.
A reaction in which daughter DNAs are synthesized using the parental DNAs as the template.
Transferring the genetic information to the descendant generation with a high fidelity
Semi-conservative replication
Bidirectional replication
Semi-continuous replication
High fidelity
Replication starts from unwinding the dsDNA at a particular point (called origin), followed by the synthesis on each strand.
The parental dsDNA and two newly formed dsDNA form a Y-shape structure called replication fork.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Top 10 Best Ayurvedic Kidney Stone Syrups in India
apoptosis
1. “To be or not to be”
A structural approach to the regulation of NF-κB in Apoptosis
By
Rajendra K Kothinti
2. outlineoutline
Introduction: ApoptosisIntroduction: Apoptosis
NF-kB role in ApoptosisNF-kB role in Apoptosis
Structure and Function: NF-kBStructure and Function: NF-kB
Regulation of NF-kBRegulation of NF-kB
ConclusionConclusion
3. CELL DEATH
Cell death:
non programmed
(e.g., Necrosis)
Programmed way
(e.g., Apoptosis)
Characteristics :
DNA
Membrane integrity
Inflammation
Cell volume
Cell fragmentation
4. Why Apoptosis In cells ?
To maintain cell homeostasis a balance between the increase
and decrease of cell population has to be efficiently balanced.
Need to destroy cells that represent a threat to the integrity of
the organism.
Formation of the proper connections (synapses) between
neurons in the brain during development.
Formation of the fingers and toes of the fetus requires the
removal of the tissue between them.
5. Apoptosis
This phenomenon recognized prior by Carl Vogt over a 150 years
ago in studying mid wife toad development.
John Kerr et al. in 1972,
“The mechanism responsible for the physiological deletion of
cells and appears to be intrinsically programmed”.
Some times used synonymous to programmed cell death (PCD).
6. Too much apoptosis:
- Degenerative diseases,
- Parkinson’s,
- Alzheimer’s,
- Spinal Muscular atrophy,
- AIDS, etc.
Too little apoptosis:
- Cancer (by virus infection or by DNA mutations)
- Autoimmune diseases like diabetes type-I.
Pathological significance
7. What is NF-kB?
“Nuclear Factor Kappa B”
A ~300 kDa protein which is a
latent, primary transcription
factor ubiquitously found in all
cell types.
-Sidney Harris
8. What is Transcription?
DNA sequence is enzymatically
copied by an RNA polymerase to
produce a complementary RNA.
In other words, the transfer of
genetic information from DNA into
RNA which subsequently
translates to protein in cytoplasm
www.scientificpsychic.com/.../aminoacids1.html
9. What is a Transcription factor?
Protein that binds DNA at a
specific promoter or enhancer
region where it regulates
transcription.
These are selectively activated
or deactivated by other proteins
They regulate of many different
gene products. (proteins)
promoter
Genes for
different Protein.
ds-DNA
Transcription
Factor
m-RNA
Protein
RNA polymerase
Translation
n
Cytoplasm
Nucleus
10. outlineoutline
Introduction: ApoptosisIntroduction: Apoptosis
NF-kB role in ApoptosisNF-kB role in Apoptosis
Regulation of NF-kBRegulation of NF-kB
Structure and Function: NF-kBStructure and Function: NF-kB
ConclusionConclusion
11. General Picture of Apoptosis & NF-kB role
Anti
Apoptotic
Pro-
Apoptotic
NF-kB
(A Transcription
factor Protein)
+
Cell surface
Receptor
UV, Free
radicals,
Metals
Cytokines,
TNFα,
viral proteins,
and Toxins
mitochondria
Gene products
( proteins)
RNA Pol
m-RNA
Cytochrome C
Aptosome
Complex
APOPTOSIS
Inhibitor
(IKB)
latent
Kinase
IkB
12. Biochemical Pharmacology
Volume 68, Issue 6 , 15 September 2004, Pages 1071-1080
NF-kB role in Apoptosis
The majority of gene products
made by NFkB prevents
apoptosis
The dynamic bias of NF-kB for
making anti- apoptotic gene
products is critical for cell
survival.
13. General Picture of Apoptosis and NF-kB role
Anti
Apoptotic
Pro-
Apoptotic
NF-kB
(A Transcription
factor Protein)
+
Cell surface
Receptor
Metals
mitochondria
Gene products
( proteins)
RNA Pol
m-RNA
Cytochrome C
Aptosome
Complex
APOPTOSIS
Inhibitor
Inactive
14. IkB specific kinase is sequestered
in cytoplasm.
NFkB activation occurs only in
cytoplasm.
ATP is required for activation.
Ubiquitination of IkB initiates by
26s proteosome proteolysis
(Ub) n
_
_
NFkB Activation
2
2
15. Forms a immunoglobulin like fold
(beta barrel) at N and C terminal
connected by a linker loop.
N’ terminal Specificity Domain of
~190 amino acids region is
responsible for DNA specific
interactions
C’ terminal dimer interface
responsible for Dimer formation and
DNA non specific binding.
NF-kB Architecture
Structure 15 February 1995, 3:135-141
DNA
Miller
16. Protein - DNA Interaction
Protein + DNANS
Protein.DNANS
Protein.DNANS + DNAS Protein.DNAS + DNANS
Here the Protein is NFkB which is a transcription factor
DNA specific contacts: Made using DNA bases (Adenine , Guanine,
thymine and cytosine).
DNA non Specific contacts:
Are made using de oxy ribose sugar and Phospho
diester backbone.
17. NF-kB Interacts specifically with
DNA using loop region.
Binds in the major groove of the
DNA.
consensus sequence:
5’GGGGACTTTC-3’
3’CCCCTGAAAG-5’
Minor groove
NF-kB Binding to DNA Specifically
Major groove
NF-kB interacting in
major groove
18. NF-kB Nucleotide Base Specific Contacts
Structure January 1999, 7:R1–R6
P65-monomer–DNA specific
Interactions
P50-monomer-DNA Specific
interactions
19. Van der Waals Interactions
Tyrosine
Gel retardation assay
Proc. Nati. Acad. Sci. USA
Vol. 91, pp. 908-912, February 1994
20. Effect of DNA on NFkB bindingEffect of DNA on NFkB binding
Structure January 1999, 7:R1–R6
P65
P50
21. p65-mono+ DNA p65-DNA
p65-p50 + DNA p50-DNA-p65
K
p50-mono + DNA p50-DNA 379
K
nM
nM
nM
210
K
K
12
app
app
app
app
The enhanced binding is
found in binding to DNA
because of dimer interface.
Dimer binds stronger than
monomer to DNA and this
can be because of reduction
in entropy.
Kapp-apparent dissociation constant
Dimerisation is critical in binding of NF-kB to DNA
22. Dimerisation is critical in binding of NF-kB to DNA
Wild-type and Y267D/H304G
Data sets comparing dimer and
(mutant) Y267D/H304G
on a semi-logarithmic plot of concentration
versus fraction DNA bound.
DIMER
monomer
G. Ghosh, et. al, J. Biol. Chem (2002) 277, 24694–24700.
NF-kB (nM)
23. Structure of NF-kB Dimer InteractionStructure of NF-kB Dimer Interaction
N O
H
H
H
H
H
N
O
O
H
H H
Tyr-267
Val-199
N
ON
N
H
N
OS
H
H
H
H H
H
H
H
N
O
N
N
N
H
H
H
O
N
O
O
H
H H
H
H
H
H
H
H
Arg-252
Glu65
Structure January 1999, 7:R1–R6
DIMER INTERACTION WITH DNA
DNA
p50
p65
His304Cys
24. outlineoutline
Introduction: ApoptosisIntroduction: Apoptosis
NF-kB role in ApoptosisNF-kB role in Apoptosis
Structure and Function: NF-kBStructure and Function: NF-kB
Regulation of NF-kBRegulation of NF-kB
ConclusionConclusion
27. Cytoplasm Nucleus
NFkB-NLS-carrier protein
Conf. 2
NFkB-NLS-carrier protein
Conf. 1
GTP
Carrier protein-GTP
Active
NFkB-IkB-NES
NFkB
NFkB-IkB-NES-(Ser)2Carrier protein -GTP
2ATP
Inactive 2ADP
Kinase
NFkB-IkB-NES-(Ser)2
Carrier protein -GTP
Carrier protein
NFkB-IkB
GDP
Regulation of Transport
kinase
IkB-(Ser)2
P03
-
P03
-
P03
-
Active
2ATP
2ADP
28. NFkB-IkB +
Conf.1
Regulation of Activation : cytoplasm to nucleusRegulation of Activation : cytoplasm to nucleus
2ATP
IkB-(UB)n-(OPO3)2
Active
proteolysis by
Ubiquitin path
way
Carrier protein + NFkB
Conf. B
Conf.2
Conf.2
Carrier protein-NFkB
Nucleus
NFkB + IkB-(OPO3
-
)2
IkB-(OPO3
-
)2+ n (UB)
+ 2ADP +2H2O
GTP + Carrier protein-NFkB Carrier protein-GTP + NFkB
Conf.2
Active
Cytoplasm
Conf. B
Conf.2
Conf.2
Conf. B Conf. A
Transcription of anti
apoptotic protein
Kinases
29. NFkB-IKB + Carrier protein + GTP NFkB-IKB-Carrier
protein -GTP
NFkB-IKB –Carrier protein –GTP NFkB-IkB + Carrier protein+ GDP
GTP ase
activity
Regulation of Inactivation: Nucleus to CytoplasmRegulation of Inactivation: Nucleus to Cytoplasm
NFkB-IKB –Carrier
protein -GTP Nuclear pore
complex
NFkB-IKB –Carrier protein -GTP
Nucleus
cytoplasm
GTP + H20 GDP + Pi
30. Cell (1998) 95, 729–731
Nuclear localization signal masking by IkBNuclear localization signal masking by IkB
NFkB-IKB
PyMOL – PDB -1NFI
IkB Prevents the export of NF-kB from
cytoplasm to nucleus by binding to
nuclear localization signal.
Ankyrin repeat
NLS -nuclear localizing signal
NES - Nuclear export signal
1
2
3
4
5
6
NLS
NES
31. (SER)2-IkB-NFkB
2 ATP
2ADP
NFkB-IKB-(SER)2
(Ubiquitin) n
NLS-NFkB-IKB- (SER)2
Ub-Ub-Ub-Ub
proteolysis
DNA + NFkB
ACTIVE
IN-ACTIVE
2 ATP
2ADP
IkB
DNA
I K Kinase
Regulation of NF-kB TransportRegulation of NF-kB Transport
Cytoplasm
Nucleus
NES
NLS
Transcription of
IkB as gene
products
DNA- NFkB
CII-kinase
P03
-
GTP + carrier protein
IKB-NFkB-GTP-carrier protein
IKB-NFkB
GTPase
carrier protein
Carrier protein
IKB
P03
-
P03
-
P03
-
32. IkB an allosteric inhibitor of (NFkB-DNA)
NFkB DNA+ NFkB.DNA
+
IkB
NFkB.IkB + DNA No Reaction
Transcription
Gene Products for
the inhibition of
apoptotic path way
CELL SURVIVAL
Kd=~12nM
Kd=~ 3.0nM
33. IN ACTIVE
Structure January 1999, 7:R1–R6
Conformational change in DNA
binding site of N’ terminal p65
subunit of NF-kB is regulated
allosterically by IkB
ACTIVE
Cell, Vol. 95, 759–770, December 11, 1998
IkB an allosteric inhibitor of (NFkB-DNA)
Structure alignment of NF-kB
34. Conclusion
NF-kB plays a critical role in deciding the cell fate.
Regulates many of the gene products which are potential
inhibitors of apoptosis.
Dimerisation is playing a vital role in NFkB specific recognition of
DNA.
DNA specific interactions are contributed by loop regions.
IkB is important inhibitor of NFkB.
35. THANK YOU
•Dr. David Petering
•Dr. Niloofar Tabatabai
•Sue Krezoski
•Jeff Meeusen
•Chris Oberle
•Ujala
•Cristin
•Wanrong